Acrivon Therapeutics, Inc. (ACRV) Institutional Ownership

Institutions by Trading Activity

38,795,745Shares Outstanding

658Shares held by institutions

$1,066Value of institutional holdings

2.70%Institutional ownership %

-19.98%Shares Changed QoQ

5No. of institutional investors

According to SEC filings for the period ending December 2025, Acrivon Therapeutics, Inc. (NASDAQ:ACRV) is held by 5 institutional firms.

Acrivon Therapeutics saw its institutional ownership percentage fell to 2.7% in December 2025 from 45.0% in September 2025.
The company experienced a -19.98% quarterly change in institutional shares held, alongside a decrease of 92.06% in total owners annually.
Among the 5 institutional holders of Acrivon Therapeutics, 2 added to their stakes while 1 trimmed their positions and 2 held steady.
The aggregate institutional position in Acrivon Therapeutics now stands at 1.05Mn shares as of December 2025, after investors decreased their holdings (down by 261.69K shares quarter on quarter which is down 22.20Mn shares year over year).
VANGUARD GROUP INC continues to be the largest institutional holder of Acrivon Therapeutics as of December 31, 2025, with a position of 698.86K shares, representing 1.80% of the company's outstanding stock.
Among the most significant buyers of Acrivon Therapeutics during December 2025 were VANGUARD GROUP INC (72.71K), OPTIMA CAPITAL LLC (278).
Leading sellers of Acrivon Therapeutics stock in December 2025 included UBS Group AG (334.68K).
The top 5 institutional holders of Acrivon Therapeutics for the quarter ending December 2025 included VANGUARD GROUP INC (698.86K), UBS Group AG (348.54K), NISA INVESTMENT ADVISORS, LLC (584), OPTIMA CAPITAL LLC (278), SBI Securities Co., Ltd. (74).

658 Total Shares Held

Rows:

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
RA CAPITAL MANAGEMENT, L.P.	30 Sep, 2025	8,340,508	0	0.00%	$15,096,319.00
Sands Capital Alternatives, LLC	30 Sep, 2025	2,122,605	0	0.00%	$3,841,915.00
CITADEL ADVISORS LLC	30 Sep, 2025	1,541,326	1,541,326	0.00%	$2,789,800.00
WELLINGTON MANAGEMENT GROUP LLP	30 Sep, 2025	888,130	0	0.00%	$1,607,515.00
UBS Group AG	30 Sep, 2025	683,218	682,763	150,057.80%	$1,236,624.00
VANGUARD GROUP INC	30 Sep, 2025	626,148	32,901	5.55%	$1,133,327.00
RENAISSANCE TECHNOLOGIES LLC	30 Sep, 2025	623,400	114,105	22.40%	$1,128,354.00
ACORN CAPITAL ADVISORS, LLC	30 Sep, 2025	405,237	0	0.00%	$733,479.00
BlackRock, Inc.	30 Sep, 2025	330,957	-76,665	-18.81%	$599,032.00
TWO SIGMA INVESTMENTS, LP	30 Sep, 2025	319,205	138,033	76.19%	$577,761.00
JANE STREET GROUP, LLC	30 Sep, 2025	289,248	-22,581	-7.24%	$523,539.00
GEODE CAPITAL MANAGEMENT, LLC	30 Sep, 2025	192,033	27,671	16.84%	$347,717.00
MILLENNIUM MANAGEMENT LLC	30 Sep, 2025	185,234	-111,005	-37.47%	$335,274.00
MARSHALL WACE, LLP	30 Sep, 2025	149,715	-31,472	-17.37%	$270,984.00
TWO SIGMA ADVISERS, LP	30 Sep, 2025	136,500	103,900	318.71%	$247,065.00
Squarepoint Ops LLC	30 Sep, 2025	104,324	-48,281	-31.64%	$188,826.00
ACADIAN ASSET MANAGEMENT LLC	30 Sep, 2025	92,004	92,004	0.00%	$165.00
STATE STREET CORP	30 Sep, 2025	67,145	0	0.00%	$121,532.00
MORGAN STANLEY	30 Sep, 2025	57,160	-5,856	-9.29%	$103,460.00
ALGERT GLOBAL LLC	30 Sep, 2025	44,648	44,648	0.00%	$81.00

1 - 20 of 46